Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Calimmune, Inc.
Sponsor:
Information provided by (Responsible Party):
Calimmune, Inc.
ClinicalTrials.gov Identifier:
NCT01734850
First received: November 19, 2012
Last updated: January 27, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)